A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study

Background: Recent studies have reported findings regarding the addition of pegylated interferon aligned -alpha (Peg- IFNα) to nucleos (t) analog ideas. This study was designed to compare the efficacy of Peg- IFNα therapy and tenofovir disoproxil fumarate (TDF) in combination with each treatment separately.


Methods: In this open-label, randomized clinical trial, treatment-naive hepatitis B e antigen (HBeAg) -negative patients were randomly assigned to three treatment groups: Group A: Peg- IFNα (180 mcg / week) with TDF (300 mg / day); Group B: TDF (300 mg / day); and Group C: Peg- IFNα (180 mcg / week). intervention runs 48 weeks and patients were followed every 12 weeks. Primary endpoint was the burden of HBV DNA <20 IU / mL.


Results: Group A, B and C, each consisting of 22, 23 and 22 patients, respectively. The number of patients with HBV DNA suppression in group A was significantly higher than in group B and C (P = 0.034). No significant differences were observed in the trend of normalization of serum ALT levels between the three groups (P = 0.082). At week 48, the combination therapy was significantly more effective in suppressing HBV DNA concentrations below detection levels of TDF monotherapy (OR = 2.1, 95% CI: 1.18 to 4.15; P = 0.034). In addition, the comparison between the monotherapy arm revealed that both interventions have the same effect on the overall outcome (OR = 1.24, 95% CI: 1.02 to 5.8; P = 0.062).


Conclusion: A Peg- IFNα and TDF combination therapy resulted in a good and safe virologic response in patients with HBeAg negative. Monotherapy with Peg-IFNα or TDF benefit was limited compared.

 A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study
A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study

Double-blind, randomized trial to compare the efficacy of escitalopram compared to citalopram for depression induced interferon in patients with hepatitis C

Objective: The objective of this study was to compare two antidepressant drug citalopram and escitalopram on the basis of success in depressed patients of hepatitis C patients who received interferon.


Methods: In a double-blind randomized trial, patients with hepatitis C visit the National institute liver and gastro intestinal diseases (NILGID), Dow University Hospital, screened for depression before starting treatment with interferon. Institutional review board approval was obtained and references no.is mail: IRB-682 / DUHS / approval / 2016/169. Patients with a history of depression were excluded from the study. The patients who started therapy with interferon assessed for depression at baseline and then at each visit. Those who develop depression were randomly assigned to receive either citalopram or escitalopram. treatment groups was assessed by a scale of depression every time they visit the clinic. Two antidepressants compared to their success in an interval of 4 weeks, 8weeks and then 12 weeks.

anti-IFNA16

YF-PA12588 50 ug
EUR 435.6
Description: Mouse polyclonal to IFNA16

anti-IFNA16

YF-PA12589 100 ug
EUR 483.6
Description: Rabbit polyclonal to IFNA16

IFNA16 ORF Vector (Human) (pORF)

ORF021358 1.0 ug DNA Ask for price

IFNA16 Conjugated Antibody

C37641 100ul
EUR 476.4

Human IFNA16 shRNA Plasmid

20-abx952338
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

IFNA16 Antibody, HRP conjugated

1-CSB-PA011036LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

IFNA16 Antibody, FITC conjugated

1-CSB-PA011036LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

IFNA16 Antibody, Biotin conjugated

1-CSB-PA011036LD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against IFNA16. Recognizes IFNA16 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

IFNA16 Protein Vector (Human) (pPB-C-His)

PV085429 500 ng Ask for price

IFNA16 Protein Vector (Human) (pPB-N-His)

PV085430 500 ng Ask for price

IFNA16 Protein Vector (Human) (pPM-C-HA)

PV085431 500 ng Ask for price

IFNA16 Protein Vector (Human) (pPM-C-His)

PV085432 500 ng Ask for price

Interferon Alpha 16 (IFNA16) Antibody

20-abx211357
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Recombinant Interferon Alpha 16 (IFNa16)

4-RPG968Mu01
  • EUR 636.10
  • EUR 294.00
  • EUR 2055.36
  • EUR 765.12
  • EUR 1410.24
  • EUR 501.60
  • EUR 4958.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Interferon Alpha 16 expressed in: E.coli

IFNA16 sgRNA CRISPR Lentivector set (Human)

K1020001 3 x 1.0 ug
EUR 406.8

Human Interferon Alpha 16 (IFNa16) Protein (Active)

20-abx655681
  • EUR 1345.20
  • EUR 493.20
  • EUR 4468.80
  • EUR 1629.60
  • EUR 910.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Interferon alpha- 16, IFNA16 ELISA KIT

ELI-48218h 96 Tests
EUR 988.8

IFNA16 sgRNA CRISPR Lentivector (Human) (Target 1)

K1020002 1.0 ug DNA
EUR 184.8

IFNA16 sgRNA CRISPR Lentivector (Human) (Target 2)

K1020003 1.0 ug DNA
EUR 184.8

IFNA16 sgRNA CRISPR Lentivector (Human) (Target 3)

K1020004 1.0 ug DNA
EUR 184.8

Human Interferon Alpha 16(IFNa16)ELISA Kit

QY-E03458 96T
EUR 433.2

IFNA16 3'UTR GFP Stable Cell Line

TU060478 1.0 ml
EUR 1672.8

IFNA16 3'UTR Luciferase Stable Cell Line

TU010478 1.0 ml
EUR 1672.8

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K1020005 3 x 1.0 ug
EUR 451.2

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K1020006 1.0 ug DNA
EUR 200.4

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K1020007 1.0 ug DNA
EUR 200.4

IFNA16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K1020008 1.0 ug DNA
EUR 200.4

Cas9 Nickase Lentiviral Vector

K005 10 ug
EUR 184.8

Cas9 Nuclease Lentiviral Vector

K002 10 ug
EUR 184.8

dCas9-KRAB Lentiviral Vector

K203 10 ug
EUR 273.6

pLenti-GFP Lentiviral Control Vector

LTV-400 100 µL
EUR 741.6
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pSMPUW-MNDnLacZ Lentiviral Control Vector

LTV-402 10 µg
EUR 741.6
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

Cas9 Double Mutant Lentiviral Vector

K012 10 ug
EUR 643.2

pSMPUW-Puro Lentiviral Expression Vector

VPK-212 10 µg
EUR 748.8
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-Neo Lentiviral Expression Vector

VPK-213 10 µg
EUR 748.8
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-Hygro Lentiviral Expression Vector

VPK-214 10 µg
EUR 748.8
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-GFP-Puro Lentiviral Control Vector

LTV-401 10 µg
EUR 741.6
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pLenti-RFP-Puro Lentiviral Control Vector

LTV-403 100 µL
EUR 741.6
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pSMPUW-GFP-LC3 Lentiviral Expression Vector

LTV-801 10 µg
EUR 1444.8
Description: Expression vector contains a fusion of GFP and LC3. A separate GFP control vector is also included.

ESR1 Lentiviral Vector (Human) (pLenti-II)

LV010008 1.0 ug DNA
EUR 379.2

pSMPUW Universal Lentiviral Expression Vector (Promoterless)

VPK-211 10 µg
EUR 748.8
Description: Clone your gene of interest and a gene-specific promoter into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293T or 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Puro Lentiviral Expression Vector

VPK-215 10 µg
EUR 748.8
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Neo Lentiviral Expression Vector

VPK-216 10 µg
EUR 748.8
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Hygro Lentiviral Expression Vector

VPK-217 10 µg
EUR 748.8
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Blasticidin Lentiviral Expression Vector

VPK-219 10 µg
EUR 748.8
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

ERAF Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810237 1.0 ug DNA
EUR 379.2

ERAF Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810241 1.0 ug DNA
EUR 379.2

ERAF Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810242 1.0 ug DNA
EUR 379.2

C6orf218 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810243 1.0 ug DNA
EUR 379.2

C6orf218 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810247 1.0 ug DNA
EUR 379.2

C6orf218 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810248 1.0 ug DNA
EUR 379.2

BXDC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810249 1.0 ug DNA
EUR 379.2

BXDC1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810253 1.0 ug DNA
EUR 379.2

BXDC1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810254 1.0 ug DNA
EUR 379.2

C17orf45 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810255 1.0 ug DNA
EUR 379.2

C17orf45 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810259 1.0 ug DNA
EUR 379.2

C17orf45 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810260 1.0 ug DNA
EUR 379.2

FAM86C Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810261 1.0 ug DNA
EUR 379.2

FAM86C Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810265 1.0 ug DNA
EUR 379.2

FAM86C Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810266 1.0 ug DNA
EUR 379.2

C3orf31 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810267 1.0 ug DNA
EUR 379.2

C3orf31 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810271 1.0 ug DNA
EUR 379.2

C3orf31 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810272 1.0 ug DNA
EUR 379.2

C13orf16 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810279 1.0 ug DNA
EUR 379.2

C13orf16 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810283 1.0 ug DNA
EUR 379.2

C13orf16 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810284 1.0 ug DNA
EUR 379.2

C21ORF55 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810285 1.0 ug DNA
EUR 379.2

C21ORF55 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810289 1.0 ug DNA
EUR 379.2

C21ORF55 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810290 1.0 ug DNA
EUR 379.2

FLJ10357 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810291 1.0 ug DNA
EUR 379.2

FLJ10357 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810295 1.0 ug DNA
EUR 379.2

FLJ10357 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810296 1.0 ug DNA
EUR 379.2

C13orf3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810297 1.0 ug DNA
EUR 379.2

C13orf3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810301 1.0 ug DNA
EUR 379.2

C13orf3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810302 1.0 ug DNA
EUR 379.2

ARL17 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810303 1.0 ug DNA
EUR 379.2

ARL17 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810307 1.0 ug DNA
EUR 379.2

ARL17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810308 1.0 ug DNA
EUR 379.2

HSPC047 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810309 1.0 ug DNA
EUR 379.2

HSPC047 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810313 1.0 ug DNA
EUR 379.2

HSPC047 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810314 1.0 ug DNA
EUR 379.2

C9orf68 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810315 1.0 ug DNA
EUR 379.2

C9orf68 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810319 1.0 ug DNA
EUR 379.2

C9orf68 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810320 1.0 ug DNA
EUR 379.2

C18orf22 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810321 1.0 ug DNA
EUR 379.2

C18orf22 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810325 1.0 ug DNA
EUR 379.2

C18orf22 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810326 1.0 ug DNA
EUR 379.2

KIAA0774 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810327 1.0 ug DNA
EUR 379.2

KIAA0774 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810331 1.0 ug DNA
EUR 379.2

KIAA0774 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810332 1.0 ug DNA
EUR 379.2

BXDC5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810333 1.0 ug DNA
EUR 379.2

BXDC5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810337 1.0 ug DNA
EUR 379.2

BXDC5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810338 1.0 ug DNA
EUR 379.2

IL8RA Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810339 1.0 ug DNA
EUR 379.2

IL8RA Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810343 1.0 ug DNA
EUR 379.2

IL8RA Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810344 1.0 ug DNA
EUR 379.2

RBM9 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810345 1.0 ug DNA
EUR 379.2

RBM9 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810349 1.0 ug DNA
EUR 379.2

RBM9 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810350 1.0 ug DNA
EUR 379.2

FAM62B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810351 1.0 ug DNA
EUR 379.2

FAM62B Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810355 1.0 ug DNA
EUR 379.2

FAM62B Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810356 1.0 ug DNA
EUR 379.2

BC013798 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810357 1.0 ug DNA
EUR 379.2

BC013798 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810361 1.0 ug DNA
EUR 379.2

BC013798 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810362 1.0 ug DNA
EUR 379.2

RTCD1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810363 1.0 ug DNA
EUR 379.2

RTCD1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810367 1.0 ug DNA
EUR 379.2

RTCD1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810368 1.0 ug DNA
EUR 379.2

TTC15 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810369 1.0 ug DNA
EUR 379.2

TTC15 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810373 1.0 ug DNA
EUR 379.2

TTC15 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810374 1.0 ug DNA
EUR 379.2

RAD51L1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810375 1.0 ug DNA
EUR 379.2

RAD51L1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810379 1.0 ug DNA
EUR 379.2

RAD51L1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810380 1.0 ug DNA
EUR 379.2

TSP50 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810381 1.0 ug DNA
EUR 379.2

TSP50 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810385 1.0 ug DNA
EUR 379.2

TSP50 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810386 1.0 ug DNA
EUR 379.2

TMEM22 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810387 1.0 ug DNA
EUR 379.2

TMEM22 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810391 1.0 ug DNA
EUR 379.2

TMEM22 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810392 1.0 ug DNA
EUR 379.2

KTELC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810393 1.0 ug DNA
EUR 379.2

KTELC1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810397 1.0 ug DNA
EUR 379.2

KTELC1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810398 1.0 ug DNA
EUR 379.2

C9orf68 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810399 1.0 ug DNA
EUR 379.2

C9orf68 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810403 1.0 ug DNA
EUR 379.2

C9orf68 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810404 1.0 ug DNA
EUR 379.2

LASS4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810405 1.0 ug DNA
EUR 379.2

LASS4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810409 1.0 ug DNA
EUR 379.2

LASS4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810410 1.0 ug DNA
EUR 379.2

TMEM49 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810411 1.0 ug DNA
EUR 379.2

TMEM49 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810415 1.0 ug DNA
EUR 379.2

TMEM49 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810416 1.0 ug DNA
EUR 379.2

C2orf24 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810417 1.0 ug DNA
EUR 379.2

C2orf24 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810421 1.0 ug DNA
EUR 379.2

C2orf24 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810422 1.0 ug DNA
EUR 379.2

C1orf62 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810423 1.0 ug DNA
EUR 379.2

C1orf62 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810427 1.0 ug DNA
EUR 379.2

C1orf62 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810428 1.0 ug DNA
EUR 379.2

JMJD5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810429 1.0 ug DNA
EUR 379.2

JMJD5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810433 1.0 ug DNA
EUR 379.2

JMJD5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810434 1.0 ug DNA
EUR 379.2

AKD2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810435 1.0 ug DNA
EUR 379.2

AKD2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810439 1.0 ug DNA
EUR 379.2

AKD2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810440 1.0 ug DNA
EUR 379.2

WDR8 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810441 1.0 ug DNA
EUR 379.2

WDR8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810445 1.0 ug DNA
EUR 379.2

WDR8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810446 1.0 ug DNA
EUR 379.2

LOC90379 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810447 1.0 ug DNA
EUR 379.2

LOC90379 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810451 1.0 ug DNA
EUR 379.2

LOC90379 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810452 1.0 ug DNA
EUR 379.2

SFRS17A Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810453 1.0 ug DNA
EUR 379.2

SFRS17A Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810457 1.0 ug DNA
EUR 379.2

SFRS17A Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810458 1.0 ug DNA
EUR 379.2

FLJ13052 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810459 1.0 ug DNA
EUR 379.2

FLJ13052 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810463 1.0 ug DNA
EUR 379.2

FLJ13052 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810464 1.0 ug DNA
EUR 379.2

C6orf182 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810465 1.0 ug DNA
EUR 379.2

C6orf182 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810469 1.0 ug DNA
EUR 379.2

C6orf182 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810470 1.0 ug DNA
EUR 379.2

HNRPK Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810471 1.0 ug DNA
EUR 379.2

HNRPK Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810475 1.0 ug DNA
EUR 379.2

HNRPK Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810476 1.0 ug DNA
EUR 379.2

C20ORF158 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810477 1.0 ug DNA
EUR 379.2

C20ORF158 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810481 1.0 ug DNA
EUR 379.2

C20ORF158 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810482 1.0 ug DNA
EUR 379.2

PCTK1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810483 1.0 ug DNA
EUR 379.2

PCTK1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810487 1.0 ug DNA
EUR 379.2

PCTK1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810488 1.0 ug DNA
EUR 379.2

IGHGA1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810489 1.0 ug DNA
EUR 379.2

IGHGA1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810493 1.0 ug DNA
EUR 379.2

IGHGA1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810494 1.0 ug DNA
EUR 379.2

C8orf41 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810495 1.0 ug DNA
EUR 379.2

C8orf41 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810499 1.0 ug DNA
EUR 379.2

C8orf41 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810500 1.0 ug DNA
EUR 379.2

C19orf61 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810501 1.0 ug DNA
EUR 379.2

C19orf61 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810505 1.0 ug DNA
EUR 379.2

C19orf61 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810506 1.0 ug DNA
EUR 379.2

C10orf33 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810507 1.0 ug DNA
EUR 379.2

C10orf33 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810511 1.0 ug DNA
EUR 379.2

C10orf33 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810512 1.0 ug DNA
EUR 379.2

KIAA1434 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810513 1.0 ug DNA
EUR 379.2

KIAA1434 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810517 1.0 ug DNA
EUR 379.2

KIAA1434 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810518 1.0 ug DNA
EUR 379.2

LOC23117 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810519 1.0 ug DNA
EUR 379.2

LOC23117 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810523 1.0 ug DNA
EUR 379.2

LOC23117 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810524 1.0 ug DNA
EUR 379.2

C2orf67 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810525 1.0 ug DNA
EUR 379.2

C2orf67 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV810529 1.0 ug DNA
EUR 379.2

C2orf67 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV810530 1.0 ug DNA
EUR 379.2

MGC10814 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV810531 1.0 ug DNA
EUR 379.2


Results: In the present study 80 patients were randomized to receive either citalopram or escitalopram. The research result was better in patients treated with escitalopram. Significant changes in depression scores from the beginning to the end of the study was greater in the escitalopram group is 10.41 compared with citalopram group is 14.17. Differences in depression scores were also calculated as 4.28 and.3.76 (p <0.001) for both drugs at week 8 and week 12 respectively, which were statistically significant. Difference in depression scores were also calculated for the sex of 0.576 (p = 0.497) and age of 0.950 (p = 0.265), were found to be significant, statistically.


Conclusion: The results show the superiority of escitalopram over citalopram, the drug is twice as potent as racemic mixtures. In addition the drug is well tolerated and showed a better effect. Escitalopram proven to be a safer alternative to citalopram.